Evidence mapPaperPMID 42420644Full record

ReviewNature protocols2026

Tutorial: strategies for targeting organelles using nanoparticles.

Na Feng, Jialu Gao, Leyi Wang, Yiliang Qin, Lei Zheng, Ben Zhong Tang, Jing Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Na FengDepartment of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jialu GaoDepartment of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. 2020103060010@whu.edu.cn.
Leyi WangDepartment of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yiliang QinDepartment of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Lei ZhengDepartment of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. nfyyzhenglei@smu.edu.cn.ORCID http://orcid.org/0000-0003-2576-8780
Ben Zhong TangGuangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen, China. tangbenz@cuhk.edu.cn.ORCID http://orcid.org/0000-0002-0293-964X
Jing ZhangDepartment of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. zjsilence@i.smu.edu.cn.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31971293National Natural Science Foundation of China (National Science Foundation of China) 52573325
6 · The paper itself

Abstract

Dysfunctions in specific subcellular organelles are fundamentally implicated in the pathogenesis of a wide range of critical diseases. Targeting these organelles has thus emerged as a promising strategy for achieving precise diagnostics and effective therapies. Nanotechnology serves as a powerful platform in this endeavor, enabling the rational design of nanoparticles with tailored physicochemical properties to control their intracellular trafficking and localization. This Tutorial systematically examines design strategies for nanoparticles that target key organelles, including mitochondria, lysosomes, the nucleus, the endoplasmic reticulum and the Golgi apparatus. Here we summarize organelle-specific targeting design strategies, elucidate the underlying fundamental principles and describe experimental methodologies for validating subcellular localization. Furthermore, we discuss emerging frontiers in the field. We aim to provide a systematic and actionable guide for researchers in materials science, chemistry, biology and medicine, supporting the development of next-generation organelle-targeted nanomedicines for both fundamental research and translational applications.

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.